SCHEMBL15020001

SCHEMBL15020001

CN(C)C1=CC(=O)C(Nc2ccc(N)cc2)=CC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.37
▸ L3MBTL1 Q9Y468 4/20 0.37
▸ MAPT P10636 4/20 0.37
▸ HTT P42858 3/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NR4A1 P22736 1/20 0.37
▸ MAPK1 P28482 4/20 0.36
▸ CASP3 P42574 3/20 0.36
▸ BLM P54132 3/20 0.36
▸ SENP8 Q96LD8 3/20 0.36
▸ SENP7 Q9BQF6 3/20 0.36
▸ SENP6 Q9GZR1 3/20 0.36
▸ TP53 P04637 2/20 0.36
▸ TDP2 O95551 2/20 0.36
▸ NSD2 O96028 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15039382 0.84 DNM1 (0.44) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL15019989 0.83 DNM1 (0.73) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL11390354 0.79 DNM1 (0.55) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL15020510 0.78 DNM1 (0.41) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL16285769 0.74 DNM1 (0.40) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL11392481 0.73 DNM1 (0.49) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL15020504 0.72 MALT1 (0.32) DNM1KDM4EMALT1KDRRAB9A
SCHEMBL15022915 0.71 DNM1 (0.50) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL15039674 0.71 DNM1 (0.46) DNM1ALDH1A1L3MBTL1MAPTHTT
SCHEMBL15020148 0.71 DNM1 (0.46) DNM1ALDH1A1L3MBTL1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2791106-B1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEROF OREAL (FR) 2016-05-18 — — EP claimed
EP-2791106-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2014-10-22 — — EP claimed
WO-2013087770-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2013-06-20 — — WO claimed
EP-2791106-B1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEROF OREAL (FR) 2016-05-18 — — EP disclosed
EP-2791106-B1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEROF OREAL (FR) 2016-05-18 — — EP disclosed
US-9233057-B2 Particular quinone direct dyes, dye composition comprising at least one such dye, implementation process therefor and use thereof L'OREAL (FR) 2016-01-12 — — US disclosed
US-20140360523-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2014-12-11 — — US disclosed
EP-2791106-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2014-10-22 — — EP disclosed
WO-2013087770-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2013-06-20 — — WO disclosed
WO-2013087770-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140360523-A1 PARTICULAR QUINONE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, IMPLEMENTATION PROCESS THEREFOR AND USE THEREOF KRT18, SQOR, NDUFB7 DNM1 961/4885ALDH1A1 330/4885L3MBTL1 4804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback